Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

The Spectranetics Corp.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

The Spectranetics Corp.

Regulatory records
2
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 2 FDA records to the applicant name The Spectranetics Corp.. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Nov 24, 2025 to Mar 19, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code ONU appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P160049, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 6531 Dumbarton Cir., Fremont, CA, 94555. Recorded on P160049/S028, decision dated Mar 19, 2026.

Changes described in PMA records

P160049/S028: Stellarex 0.035 OTW Drug-Coated Angioplasty Balloon

FDA’s recorded scope: to incorporate a change to the nylon balloon supplier site for the Stellarex 0.035 OTW Drug-coated Angioplasty Balloon and to reduce the test frequency for the Balloon Burst Test of the Stellarex 035 PTA catheter assembly

Mar 19, 2026 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
The Spectranetics Corp.PMA supplementMar 19, 2026FDA
The Spectranetics Corp.PMA supplementNov 24, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.